Frank Brecher - CompuGroup Medical Executive
| CMPUY Stock | USD 32.38 0.00 0.00% |
Executive
Mr. Frank Brecher was Member of the Management Board and Chief Process Officer of CompuGroup Medical Aktiengesellschaft since April 1 2015. He was employed with CompuGroup Medical since 1998 initially occupying various management positions in the Company dental software business. Beginning in late 2007 he was responsible for CGMs business operations in the hospital clinic and rehabilitation sector in Germany. In 2011 Mr. Brecher was a key manager involved in the acquisition of LAUERFISCHER and played a role in the integration of this new subsidiary in CGM. At the end of 2011 Mr. Brecher was appointed to the Executive Board of CGM Deutschland AG. Since April 2013 Mr. Brecher has also led and coordinated the worldwide rollout of CGMs new uniform IT platform OneGroup IT. since 2015.
| Age | 44 |
| Tenure | 9 years |
| Phone | 49 261 8000 0 |
| Web | https://www.cgm.com |
CompuGroup Medical Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1153 %, meaning that it generated $0.1153 on every $100 dollars invested by stockholders. CompuGroup Medical's management efficiency ratios could be used to measure how well CompuGroup Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michele OConnor | Veeva Systems Class | 47 | |
| George Newcomb | GE HealthCare Technologies | 57 | |
| Betty Larson | GE HealthCare Technologies | 48 | |
| Kristine Diamond | Veeva Systems Class | 56 | |
| Steve Lindsay | HealthEquity | N/A | |
| Nitsa Zuppas | Veeva Systems Class | 47 | |
| Carolynne Borders | GE HealthCare Technologies | N/A | |
| Amy Landucci | Solventum Corp | N/A | |
| Jacques Mourrain | Veeva Systems Class | N/A | |
| Brad Bennion | HealthEquity | N/A | |
| Jahid Khandaker | GE HealthCare Technologies | N/A | |
| MS MD | GE HealthCare Technologies | 52 | |
| Paul Harrington | Solventum Corp | N/A | |
| Kenneth Stacherski | GE HealthCare Technologies | 52 | |
| Frank Esq | GE HealthCare Technologies | 59 | |
| Richard Putnam | HealthEquity | N/A | |
| Rana Strellis | GE HealthCare Technologies | N/A | |
| Mary Wilcox | Solventum Corp | N/A | |
| Tia Padia | HealthEquity | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 |
CompuGroup Medical Leadership Team
Elected by the shareholders, the CompuGroup Medical's board of directors comprises two types of representatives: CompuGroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CompuGroup. The board's role is to monitor CompuGroup Medical's management team and ensure that shareholders' interests are well served. CompuGroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CompuGroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angela Teufer, Connectivity DACH | ||
| Rene Obermann, Member of the Supervisory Board | ||
| Lothar Wild, Member of the Supervisory Board | ||
| Uwe Eibich, Executive VP of Central Europe and Member of Management Board | ||
| Klaus Esser, Deputy Chairman of the Supervisory Board | ||
| Emanuele Mugnani, MD Board | ||
| Ulrike Flach, Member of the Supervisory Board | ||
| Christian Teig, CFO, Fin. Director and Member of Management Board | ||
| Helge Wei, VP Connectivity | ||
| Hannes Reichl, MD Board | ||
| Alexander Weimer, Head Communications | ||
| Daniel Gotthardt, Member of the Supervisory Board | ||
| Michael Franz, Co Communication | ||
| Oliver Bruzek, Chief Affairs | ||
| Frank Gotthardt, Chairman of Management Board and CEO | ||
| MBA LLM, MD CFO | ||
| Claudia Thom, Co Relations | ||
| Eckart Pech, MD Board | ||
| Frank Brecher, Chief Process Officer and Member of Management Board | ||
| Karl Gruener, Member of the Supervisory Board |
CompuGroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CompuGroup Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 25.48 X | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B |
Pair Trading with CompuGroup Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CompuGroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CompuGroup Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with CompuGroup OTC Stock
| 0.83 | MTHRF | M3 Inc | PairCorr |
Moving against CompuGroup OTC Stock
| 0.9 | GEHC | GE HealthCare Techno | PairCorr |
| 0.89 | TM | Toyota Motor Financial Report 8th of May 2024 | PairCorr |
| 0.76 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
| 0.72 | WF | Woori Financial Group Financial Report 21st of May 2024 | PairCorr |
| 0.66 | KB | KB Financial Group Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to CompuGroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CompuGroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CompuGroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CompuGroup Medical SE to buy it.
The correlation of CompuGroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CompuGroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CompuGroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CompuGroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical SE. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for CompuGroup OTC Stock analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |